Fajgenbaum, David C.

Cytokine storm

Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine

COVID-19 Clinical Research StudiesAutoimmune and Inflammatory Disorders Research

Cited by 3,196

Overview of Castleman disease

Dispenzieri, A., & Fajgenbaum, D. C. (2020) · Blood

Viral-associated cancers and disordersLymphadenopathy Diagnosis and Analysis

Cited by 487

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease

Iwaki, N., Fajgenbaum, D. C., Nabel, C. S., Gion, Y., Kondo, E., Kawano, M., Masunari, T., Yoshida, I., Moro, H., Nikkuni, K., et al. (2016) · American Journal of Hematology

Viral-associated cancers and disordersIgG4-Related and Inflammatory Diseases

Cited by 296

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

Fajgenbaum, D. C., Langan, R.-A., Japp, A. S., Partridge, H. L., Pierson, S. K., Singh, A., Arenas, D. J., Ruth, J. R., Nabel, C. S., Stone, K., et al. (2019) · Journal of Clinical Investigation

IgG4-Related and Inflammatory DiseasesViral-associated cancers and disorders

Cited by 147

Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease

Pierson, S. K., Stonestrom, A. J., Shilling, D., Ruth, J., Nabel, C. S., Singh, A., Ren, Y., Stone, K., Li, H., van Rhee, F., et al. (2018) · American Journal of Hematology

Viral-associated cancers and disordersIgG4-Related and Inflammatory Diseases

Cited by 90

Increased mTOR activation in idiopathic multicentric Castleman disease

Arenas, D. J., Floess, K., Kobrin, D., Pai, R.-A. L., Srkalovic, M. B., Tamakloe, M.-A., Rasheed, R., Ziglar, J., Khor, J., Parente, S. A. T., et al. (2020) · Blood

Viral-associated cancers and disordersAutoimmune and Inflammatory Disorders Research

Cited by 83

Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

Pai, R.-A. L., Japp, A. S., Gonzalez, M., Rasheed, R. F., Okumura, M., Arenas, D., Pierson, S. K., Powers, V., Layman, A. A. K., Kao, C., et al. (2020) · JCI Insight

IgG4-Related and Inflammatory DiseasesAutoimmune and Inflammatory Disorders Research

Cited by 68

Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review

Fajgenbaum, D. C., Khor, J. S., Gorzewski, A., Tamakloe, M.-A., Powers, V., Kakkis, J. J., Repasky, M., Taylor, A., Beschloss, A., Hernandez-Miyares, L., et al. (2020) · Infectious Diseases and Therapy

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 52

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

van Rhee, F., Rosenthal, A., Kanhai, K., Martin, R., Nishimura, K., Hoering, A., & Fajgenbaum, D. C. (2022) · Blood Advances

Viral-associated cancers and disordersIgG4-Related and Inflammatory Diseases

Cited by 48